Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain

Summary

This study is being done to test the safety and efficacy of the study drug LY3556050 for the treatment of chronic low back pain. This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

Timeline

Start

2021-05-20

Primary completion

2022-02-09

Completion

2022-02-09

Outcome

Missed primary endpoint

registry analysis (superiority test); 600 mg LY3556050 vs Placebo; Posterior Mean Difference 0.08 (95% CI -0.59 to 0.75) NCT04874636 ↗

Drugs

Indications